GLP-1
12 statements across 8 episodes · 6 bullish · 2 bearish · 5 people on the record · first statement Oct 20, 2023 by Chamath Palihapitiya · said 2 times in 1 episodes since 2024 · across every show →
Mentions by year
brought up most by David Friedberg (2)
tap a year for its mentions
2024 2 mentions in 1 episode
Everything said about GLP-1, oldest first
Oct 20, 2023 bearish
Dec 29, 2023 bullish
Oct 8, 2024 neutral
Science does not yet fully understand GLP-1's secondary metabolic effects
“What we don't even fully understand yet though, David, which is interesting is, is that there are primary effects of GLP-I. Certainly we can reproduce like in a test tube or a cell system, but then there's a whole myriad of other probably secondary effects bec…”
Oct 8, 2024
Oct 25, 2024 bearish
Feb 10, 2025 neutral
Feb 10, 2025 positive
Sep 29, 2025 bullish
Eli Lilly is starting trials for a brain-focused GLP-1 targeting mental health
“So we are now, right now, starting studies in bipolar disorder and major depressive disorder, along with these addictive hedonic pathways where you're sort of self-medicating and with a new GLP one, a different one, that probably, that has a little less weight…”
Sep 29, 2025 neutral
Sep 29, 2025 bullish
Jan 15, 2026 positive
Mar 26, 2026 positive
Bryan Johnson: GLP-1s and plasmid therapies will drive major longevity shifts
“In the future, like, I think we'll look back and we'll see GLP ones as the first big drop. Like what I can just inject myself and like it solves hunger and totally. Yeah. And then the second will probably be something like new limit or one of these Fox, one of…”